Press "esc" to clear
Go to Advanced Search

Showing results

20712080 of 2299

Article ID: 599290

A Vexing Issue in Stroke Care: When to Use Clot-Busting Drugs?

Loyola University Health System

One of the most challenging issues in stroke care involves the use of clot-busting drugs such as tPA. In Expert Review of Neurotherapeutics, stroke specialists offer guidance on commonly asked questions about the use of these drugs.

Released:
15-Feb-2013 10:45 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    15-Feb-2013 9:00 AM EST

Article ID: 579591

Cancer Research, Environment and Climate Change, Nutrition, and Mental Health - Upcoming Newswise Theme Wires

Newswise

Newswise invites press release submissions from new and current members for inclusion in our Theme Wires on a variety of topics, including; Cancer Research, Environment and Climate Change, Nutrition, and Mental Health. Each wire is also open for sponsorships to promote your organization’s campaign, product, service, or news.

Released:
15-Feb-2013 9:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Arts and Humanities

  • Embargo expired:
    14-Feb-2013 5:00 PM EST

Article ID: 599184

Combo of Avastin, Second Drug Shows Promise Fighting Brain Cancer

Mayo Clinic

The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.

Released:
13-Feb-2013 11:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    13-Feb-2013 5:00 PM EST

Article ID: 599214

Drug Shown to Reverse Radioiodine Resistance in Some Advanced Thyroid Cancers

Memorial Sloan Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center researchers have found that the investigational drug selumetinib shuts down the signaling of genetic mutations that prevent some patients’ thyroid cancer tumors from absorbing radioiodine, the most effective treatment for the disease.

Released:
13-Feb-2013 5:00 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
ManiSendurai.jpg

Article ID: 599194

Protein Central to Cancer Stem Cell Formation Provides New Potential Target

University of Texas M. D. Anderson Cancer Center

Researchers have identified a pivotal protein in a cellular transformation that makes a cancer cell more resistant to treatment and more capable of growing and spreading, making it an inviting new target for drug development.

Released:
13-Feb-2013 12:30 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
BoneMetastasisSingle2.jpg

Article ID: 599163

Emerging Cancer Drugs May Drive Bone Tumors

Washington University in St. Louis

Cancer drugs should kill tumors, not encourage their spread. But new evidence suggests that an otherwise promising class of drugs may actually increase the risk of tumors spreading to bone, according to researchers at Washington University School of Medicine in St. Louis.

Released:
12-Feb-2013 5:00 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
infuse.jpg

Article ID: 599001

Bevacizumab Significantly Improves Survival for Patients with Recurrent and Metastatic Cervical Cancer

National Cancer Institute (NCI) at NIH

Patients with advanced, recurrent, or persistent cervical cancer that was not curable with standard treatment who received the drug bevacizumab (Avastin) lived 3.7 months longer than patients who did not receive the drug, according to an interim analysis of a large, randomized clinical trial.

Released:
8-Feb-2013 10:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
sunitinib.png

Article ID: 599004

Sunitinib Benefits Patients with Renal Cell Carcinoma

National Cancer Institute (NCI) at NIH

Findings from clinical trial patients with metastatic renal cell carcinoma, a common kidney cancer, show they did not have accelerated tumor growth after treatment with sunitinib, in contrast to some study results in animals.

Released:
8-Feb-2013 10:00 AM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Songillustration_web.jpg
  • Embargo expired:
    7-Feb-2013 12:00 PM EST

Article ID: 598795

Researchers Uncover Key to Antidepressant Response

Johns Hopkins Medicine

Through a series of investigations in mice and humans, Johns Hopkins researchers have identified a protein that appears to be the target of both antidepressant drugs and electroconvulsive therapy. Results of their experiments explain how these therapies likely work to relieve depression by stimulating stem cells in the brain to grow and mature. In addition, the researchers say, these experiments raise the possibility of predicting individual people’s response to depression therapy, and fine-tuning treatment accordingly.

Released:
4-Feb-2013 2:00 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
cropped.jpg

Article ID: 598875

Student's Winning Plan Can Simplify Adverse Drug Reporting to FDA

University of Maryland, Baltimore

"America's Got Regulatory Science Talent" judges award student first prize.

Released:
5-Feb-2013 5:20 PM EST
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

20712080 of 2299





Chat now!